These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7765414)

  • 1. Staphylococcal protein A is a novel heterologous substrate for the HIV-1 protease.
    Marczinovits I; Molnár J; Patthy A
    J Biotechnol; 1994 Sep; 37(1):79-83. PubMed ID: 7765414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolysis of an active site peptide of lactate dehydrogenase by human immunodeficiency virus type 1 protease.
    Tomaszek TA; Moore ML; Strickler JE; Sanchez RL; Dixon JS; Metcalf BW; Hassell A; Dreyer GB; Brooks I; Debouck C
    Biochemistry; 1992 Oct; 31(42):10153-68. PubMed ID: 1420138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and characterization of chimeric rDNA proteins engineered for purification and enzymatic cleavage.
    Evans DB; Tarpley WG; Sharma SK
    Protein Expr Purif; 1991; 2(2-3):205-13. PubMed ID: 1726560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
    Goodenow MM; Bloom G; Rose SL; Pomeroy SM; O'Brien PO; Perez EE; Sleasman JW; Dunn BM
    Virology; 2002 Jan; 292(1):137-49. PubMed ID: 11878916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease.
    Prabu-Jeyabalan M; Nalivaika E; Schiffer CA
    J Mol Biol; 2000 Sep; 301(5):1207-20. PubMed ID: 10966816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoprocessing of the HIV-1 protease using purified wild-type and mutated fusion proteins expressed at high levels in Escherichia coli.
    Louis JM; McDonald RA; Nashed NT; Wondrak EM; Jerina DM; Oroszlan S; Mora PT
    Eur J Biochem; 1991 Jul; 199(2):361-9. PubMed ID: 2070793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and purification of active form of HIV-1 protease from E.coli.
    Wan M; Loh BN
    Biochem Mol Biol Int; 1995 Apr; 35(4):899-912. PubMed ID: 7627139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of amino acid insertions on the proteolysis of a staphylococcal protein A derivative in Escherichia coli.
    Yang S; Bergman T; Veide A; Enfors SO
    Eur J Biochem; 1994 Dec; 226(3):847-52. PubMed ID: 7813474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitutions at the P2' site of gag p17-p24 affect cleavage efficiency by HIV-1 protease.
    Margolin N; Heath W; Osborne E; Lai M; Vlahos C
    Biochem Biophys Res Commun; 1990 Mar; 167(2):554-60. PubMed ID: 2182016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanism of action of aspartic proteinases. 2. Conformational possibilities of an HIV-1 proteinase substrate].
    Popov ME; Kashparov IV; Popov EM
    Bioorg Khim; 1996 Jul; 22(7):510-22. PubMed ID: 8992956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoprocessing of the human immunodeficiency virus type 1 protease precursor expressed in Escherichia coli from a synthetic gene.
    Valverde V; Lemay P; Masson JM; Gay B; Boulanger P
    J Gen Virol; 1992 Mar; 73 ( Pt 3)():639-51. PubMed ID: 1545221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary structure of murine major histocompatibility complex alloantigens: amino acid sequence of the amino-terminal one hundred and seventy-three residues of the H-2Kb glycoprotein.
    Uehara H; Ewenstein BM; Martinko JM; Nathenson SG; Coligan JE; Kindt TJ
    Biochemistry; 1980 Jan; 19(2):306-15. PubMed ID: 6986168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutating P2 and P1 residues at cleavage junctions in the HIV-1 pol polyprotein. Effects on hydrolysis by HIV-1 proteinase.
    Jupp RA; Phylip LH; Mills JS; Le Grice SF; Kay J
    FEBS Lett; 1991 Jun; 283(2):180-4. PubMed ID: 2044756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the role of the S4 substrate binding site of HIV proteinases.
    Tözsér J; Gustchina A; Weber IT; Blaha I; Wondrak EM; Oroszlan S
    FEBS Lett; 1991 Feb; 279(2):356-60. PubMed ID: 2001747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of efficiently cleaved substrates for HIV-1 protease using a phage display library and use in inhibitor development.
    Beck ZQ; Hervio L; Dawson PE; Elder JH; Madison EL
    Virology; 2000 Sep; 274(2):391-401. PubMed ID: 10964781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the herpes simplex virus-1 protease cleavage sites by direct sequence analysis of autoproteolytic cleavage products.
    DiIanni CL; Drier DA; Deckman IC; McCann PJ; Liu F; Roizman B; Colonno RJ; Cordingley MG
    J Biol Chem; 1993 Jan; 268(3):2048-51. PubMed ID: 8380586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage of HIV-1 gag polyprotein synthesized in vitro: sequential cleavage by the viral protease.
    Erickson-Viitanen S; Manfredi J; Viitanen P; Tribe DE; Tritch R; Hutchison CA; Loeb DD; Swanstrom R
    AIDS Res Hum Retroviruses; 1989 Dec; 5(6):577-91. PubMed ID: 2692658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease.
    Pettit SC; Henderson GJ; Schiffer CA; Swanstrom R
    J Virol; 2002 Oct; 76(20):10226-33. PubMed ID: 12239298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystallographic analysis of human immunodeficiency virus 1 protease with an analog of the conserved CA-p2 substrate -- interactions with frequently occurring glutamic acid residue at P2' position of substrates.
    Weber IT; Wu J; Adomat J; Harrison RW; Kimmel AR; Wondrak EM; Louis JM
    Eur J Biochem; 1997 Oct; 249(2):523-30. PubMed ID: 9370363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the HIV-1 protease for excision of growth-hormone-releasing factor from synthetic and recombinant peptide precursors.
    Tomasselli AG; Mildner AA; Paddock DJ; Wheeler JS; Kubiak TM; Martin RA; Moseley WM; Mott JE; White MC; Leone JW; Heinrikson RL
    Biotechnol Appl Biochem; 1997 Aug; 26(1):39-49. PubMed ID: 9262002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.